Member Exclusive News

The week in industry: AstraZeneca and BenevolentAI collaborate to accelerate drug discovery

This week: The US FDA extends the use of BENLYSTA® to include children with lupus aged five and over, Abbvie (IL, USA) continues to gain worldwide approval of SKRIZI™ in Europe and Takeda (Tokyo, Japan) open new research facility in San Diego.

May 02, 2019

Please sign in or register for FREE

No comments yet.